// App-Quantinova.ai

2102-313 : TWO-YEAR CLINICAL OUTCOME OF THE NOBORI BIOLIMUS-ELUTING STENT VERSUS XIENCE/PROMUS EVEROLIMUS-ELUTING STENT IN REAL-WORLD CLINICAL PRACTICE

Researchers

Presenter

  • Shoichi Kuramitsu

Principal Investigators

  • Takashi Hiromasa

  • Yohei Kobayashi

  • Hiroyuki Jinnouchi

  • Takashi Morinaga

  • Toru Mazaki

  • Hisaki Masuda

  • Takenori Domei

  • Makoto Hyodo

  • Shinichi Shirai

  • Kenji Ando

Medical Centers

  • Kokura memorial hospital, Kitakyusyu, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

  • Crofelemer

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved